This quick reference guide is designed to provide easy to access information on the PBS listed biologic and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) used in the treatment of dermatology, gastroenterology and rheumatology conditions.
The monographs are listed by active ingredient with the reference brand information shown underneath. Where there are two formulations of a product (IV and subcutaneous), each formulation has its own monograph. In these cases, the active ingredient name will be followed by either (IV) or (subcut).
Paediatric indications have been listed where they are PBS funded, however further information about dosing etc. is outside the scope of this guide. Pharmacists should refer to paediatric specific references for more information about these indications.
The use of biologics and biosimilars is a rapidly changing area and this guide should not be used as the sole source of information about these medications. Where further information or clarification is required, pharmacists should refer to:
This reference guide has been developed by SHPA as part of the Targeted Therapies Alliance (TTA). Additional resources in this area which may be of use to pharmacists can be found on the NPS MedicineWise bDMARDs website.
The Society of Hospital Pharmacists of Australia Inc (SHPA) does not warrant or represent that the information provided in this guide is complete, accurate or up to date. The information is subject to change without notice and changes after publication may affect its accuracy.
SHPA makes the information available on the basis that SHPA and its employees, contributors, the authors of references used in this guide and members of the expert working group for this guide (SHPA parties) do not accept responsibility for the accuracy, currency, reliability or correctness of information.
The SHPA parties do not have any liability (to the maximum extent permitted by law) whether by reason of negligence or otherwise to users for any loss, damage, injury, cost or expense incurred, suffered or arising out of using or relying on the information. This includes whether or not any loss, damage, injury, cost or expense arises out of any error, omission or misrepresentation in the information.
Independent assessment and relevant professional advice that is specific to the circumstances should be sought before acting on the information in this guide.